XML 56 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Organization and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

Fair Value Measurements at
Reporting Date Using

 

 

 

Total

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

As of December 31, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

14,751

 

 

$

14,751

 

 

$

 

 

$

 

Total cash equivalents

 

 

14,751

 

 

 

14,751

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

71,300

 

 

 

71,300

 

 

 

 

 

 

 

U.S. agency bonds

 

 

167,103

 

 

 

 

 

 

167,103

 

 

 

 

Asset-backed securities

 

 

5,055

 

 

 

 

 

 

5,055

 

 

 

 

Corporate debt securities

 

 

1,999

 

 

 

 

 

 

1,999

 

 

 

 

Commercial paper

 

 

79,366

 

 

 

 

 

 

79,366

 

 

 

 

Total short-term investments

 

 

324,823

 

 

 

71,300

 

 

 

253,523

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total restricted cash

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total assets measured at fair value on a recurring basis

 

$

340,390

 

 

$

86,867

 

 

$

253,523

 

 

$

 

 

 

 

 

 

 

 

Fair Value Measurements at
Reporting Date Using

 

 

 

Total

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

As of December 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

12,697

 

 

$

12,697

 

 

$

 

 

$

 

Total cash equivalents

 

 

12,697

 

 

 

12,697

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

63,016

 

 

 

63,016

 

 

 

 

 

 

 

U.S. agency bonds

 

 

67,020

 

 

 

 

 

 

67,020

 

 

 

 

U.S. agency discount notes

 

 

4,334

 

 

 

 

 

 

4,334

 

 

 

 

Corporate debt securities

 

 

1,970

 

 

 

 

 

 

1,970

 

 

 

 

Commercial paper

 

 

139,250

 

 

 

 

 

 

139,250

 

 

 

 

Total short-term investments

 

 

275,590

 

 

 

63,016

 

 

 

212,574

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total restricted cash

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total assets measured at fair value on a recurring basis

 

$

289,103

 

 

$

76,529

 

 

$

212,574

 

 

$

 

Reconciliation of Cash and Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying balance sheets that sum to the amounts shown in the statements of cash flows (in thousands):

 

 

December 31,

 

 

 

2023

 

 

2022

 

 Cash and cash equivalents

 

$

19,205

 

 

$

51,426

 

 Restricted cash

 

 

816

 

 

 

816

 

 Total cash and cash equivalents and restricted cash

 

$

20,021

 

 

$

52,242

 

Summary of Short-Term Investments

The following tables summarize short-term investments (in thousands):

 

 

 

As of December 31, 2023

 

 

 

Amortized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

U.S. Treasury securities

 

$

71,072

 

 

$

242

 

 

$

(14

)

 

$

71,300

 

U.S. agency bonds

 

 

166,699

 

 

 

591

 

 

 

(187

)

 

 

167,103

 

Asset-backed securities

 

 

5,078

 

 

 

 

 

 

(23

)

 

 

5,055

 

Corporate debt securities

 

 

1,999

 

 

 

 

 

 

 

 

 

1,999

 

Commercial paper

 

 

79,310

 

 

 

56

 

 

 

 

 

 

79,366

 

Total

 

$

324,158

 

 

$

889

 

 

$

(224

)

 

$

324,823

 

 

 

 

As of December 31, 2022

 

 

 

Amortized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

U.S. Treasury securities

 

$

63,675

 

 

$

 

 

$

(659

)

 

$

63,016

 

U.S. agency bonds

 

 

67,421

 

 

 

 

 

 

(401

)

 

 

67,020

 

U.S. agency discount notes

 

 

4,321

 

 

 

13

 

 

 

 

 

 

4,334

 

Corporate debt securities

 

 

1,975

 

 

 

 

 

 

(5

)

 

 

1,970

 

Commercial paper

 

 

139,733

 

 

 

26

 

 

 

(509

)

 

 

139,250

 

Total

 

$

277,125

 

 

$

39

 

 

$

(1,574

)

 

$

275,590

 

The amortized cost and estimated fair value in the tables above exclude $2.2 million and $0.7 million of accrued interest receivable as of December 31, 2023 and 2022, respectively. Accrued interest receivable is included in prepaid expenses and other current assets in the accompanying balance sheets.
Schedule of Contractual Maturities of Available-for-sale Debt Securities

Contractual maturities of available-for-sale debt securities are as follows (in thousands):

 

 

 

As of December 31, 2023

 

 

 

Due in 1 Year or Less

 

 

Due Between 1 and 3 Years

 

 U.S. Treasury securities

 

$

34,426

 

 

$

36,874

 

 U.S. agency bonds

 

 

89,801

 

 

 

77,302

 

 Asset-backed securities

 

 

5,055

 

 

 

 

 Corporate debt securities

 

 

1,999

 

 

 

 

 Commercial paper

 

 

79,366

 

 

 

 

 Total

 

$

210,647

 

 

$

114,176

 

 

 

 

As of December 31, 2022

 

 

 

Due in 1 Year or Less

 

 

Due Between 1 and 3 Years

 

 U.S. Treasury securities

 

$

57,369

 

 

$

5,647

 

 U.S. agency bonds

 

 

37,202

 

 

 

29,818

 

 U.S. agency discount notes

 

 

4,334

 

 

 

 

 Corporate debt securities

 

 

 

 

 

1,970

 

 Commercial paper

 

 

139,250

 

 

 

 

 Total

 

$

238,155

 

 

$

37,435

 

 

Schedule of Available-for-Sale Debt Securities in an Unrealized Loss Position

The following tables summarize our available-for-sale debt securities in an unrealized loss position for which an allowance for credit losses has not been recorded, aggregated by major security type and length of time in a continuous unrealized loss position (in thousands):

 

 

As of December 31, 2023

 

 

 

Less Than 12 Months

 

 

12 Months or Longer

 

 

Total

 

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

U.S. Treasury securities

 

$

5,892

 

 

$

(14

)

 

$

 

 

$

 

 

$

5,892

 

 

$

(14

)

U.S. agency bonds

 

 

63,583

 

 

 

(169

)

 

 

9,970

 

 

 

(18

)

 

 

73,553

 

 

 

(187

)

Asset-backed securities

 

 

5,055

 

 

 

(23

)

 

 

 

 

 

 

 

 

5,055

 

 

 

(23

)

Total

 

$

74,530

 

 

$

(206

)

 

$

9,970

 

 

$

(18

)

 

$

84,500

 

 

$

(224

)

 

 

 

As of December 31, 2022

 

 

 

Less Than 12 Months

 

 

12 Months or Longer

 

 

Total

 

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

 

Fair Value

 

 

Unrealized
Losses

 

U.S. Treasury securities

 

$

15,566

 

 

$

(82

)

 

$

47,450

 

 

$

(577

)

 

$

63,016

 

 

$

(659

)

U.S. agency bonds

 

 

67,020

 

 

 

(401

)

 

 

 

 

 

 

 

 

67,020

 

 

 

(401

)

Corporate debt securities

 

 

1,970

 

 

 

(5

)

 

 

 

 

 

 

 

 

1,970

 

 

 

(5

)

Commercial paper

 

 

118,840

 

 

 

(509

)

 

 

 

 

 

 

 

 

118,840

 

 

 

(509

)

Total

 

$

203,396

 

 

$

(997

)

 

$

47,450

 

 

$

(577

)

 

$

250,846

 

 

$

(1,574

)

Summary of Potentially Dilutive Shares Not Included in the Calculation of Net Loss Per Share

Potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Common stock options

 

 

7,989,192

 

 

 

7,345,444

 

Unvested common stock

 

 

10,319

 

 

 

68,406

 

Employee stock purchase plan shares

 

 

13,796

 

 

 

10,423

 

Total potentially dilutive shares

 

 

8,013,307

 

 

 

7,424,273